Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Journal: The Lancet. Oncology
Published: December 02, 2017
Lung cancer: screening, staging, targeted therapies.
Journal: JAAPA : official journal of the American Academy of Physician Assistants
Published: February 10, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026